| pubmed-article:7544188 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7544188 | lifeskim:mentions | umls-concept:C0019196 | lld:lifeskim |
| pubmed-article:7544188 | lifeskim:mentions | umls-concept:C0042749 | lld:lifeskim |
| pubmed-article:7544188 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:7544188 | lifeskim:mentions | umls-concept:C0524910 | lld:lifeskim |
| pubmed-article:7544188 | lifeskim:mentions | umls-concept:C0279030 | lld:lifeskim |
| pubmed-article:7544188 | lifeskim:mentions | umls-concept:C1882365 | lld:lifeskim |
| pubmed-article:7544188 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:7544188 | pubmed:dateCreated | 1995-9-28 | lld:pubmed |
| pubmed-article:7544188 | pubmed:abstractText | The correlation between serum hepatitis C virus (HCV)-RNA and aminotransferase levels following completion of interferon therapy was evaluated in eight relapsed patients with chronic hepatitis C. Both HCV-RNA and aminotransferase levels were significantly increased in the relapsed patients 1 month after completion of therapy, compared to pretreatment values, despite aminotransferase levels being normal and HCV-RNA being undetectable by reverse transcription polymerase chain reaction assay at the end of therapy. The serum levels of HCV-RNA and aminotransferase were significantly elevated 1 and 2 months post-treatment. They then decreased to pretreatment values 3-5 months after the completion of therapy. Thus, in relapsed patients after the completion of therapy, the changes in HCV-RNA levels preceded the elevation in aminotransferase levels. These findings suggest a correlation between serum HCV-RNA levels and aminotransferase levels in relapsed patients with chronic hepatitis C after the completion of interferon therapy. | lld:pubmed |
| pubmed-article:7544188 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7544188 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7544188 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7544188 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7544188 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7544188 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7544188 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7544188 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:7544188 | pubmed:issn | 0944-1174 | lld:pubmed |
| pubmed-article:7544188 | pubmed:author | pubmed-author:FujiiKK | lld:pubmed |
| pubmed-article:7544188 | pubmed:author | pubmed-author:OkazakiMM | lld:pubmed |
| pubmed-article:7544188 | pubmed:author | pubmed-author:OkitaKK | lld:pubmed |
| pubmed-article:7544188 | pubmed:author | pubmed-author:HinoKK | lld:pubmed |
| pubmed-article:7544188 | pubmed:author | pubmed-author:HanadaHH | lld:pubmed |
| pubmed-article:7544188 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7544188 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:7544188 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7544188 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7544188 | pubmed:pagination | 347-50 | lld:pubmed |
| pubmed-article:7544188 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:meshHeading | pubmed-meshheading:7544188-... | lld:pubmed |
| pubmed-article:7544188 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7544188 | pubmed:articleTitle | "Rebound" phenomenon of hepatitis C viremia after interferon therapy in "relapsed" patients with chronic hepatitis C. | lld:pubmed |
| pubmed-article:7544188 | pubmed:affiliation | First Department of Internal Medicine, Yamaguchi University School of Medicine, Japan. | lld:pubmed |
| pubmed-article:7544188 | pubmed:publicationType | Journal Article | lld:pubmed |
